|
KMID : 0191120230380240209
|
|
Journal of Korean Medical Science
2023 Volume.38 No. 24 p.209 ~ p.209
|
|
|
New-Onset Fulminant Type 1 Diabetes Following SARS-CoV-2 Protein Subunit Vaccine: A Case Report and Literature Review
|
|
Lanhui Huang
Min Liang
Yuling He
|
|
|
Abstract
|
|
|
|
The ravages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide have sped up the development of relevant vaccines, which is accompanied by public concerns over possible adverse effects. We report a rare case of a 39-year-old woman who suffered from severe hyperglycemia and ketoacidosis with normal hemoglobin A1c four days after SARS-CoV-2 protein subunit vaccine, which is consistent with the diagnosis of fulminant type 1 diabetes (FT1D). She received insulin therapy and recovered after 24 days from onset of the symptoms. This is the first case of new-onset FT1D after SARS-CoV-2 protein subunit vaccination and one of only six that developed after any form of SARS-CoV-2 vaccination. We hope to raise awareness of this potential adverse consequence and recommend careful monitoring after vaccination in patients even without a medical history of diabetes.
|
|
|
KEYWORD
|
|
|
Fulminant Type 1 Diabetes, SARS-CoV-2 Vaccine, Protein Subunit Vaccine, Adverse Effects
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|